Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Racial minority patients underrepresented in 80% of hospitals, U.S. News “equity measures” find
FreeHealth Equity

Racial minority patients underrepresented in 80% of hospitals, U.S. News “equity measures” find

July 30, 2021
Vol.47 No.30
By Matthew Bin Han Ong
Ben Harder: U.S. News may use health equity measures to rank hospitals in the future
Conversation with The Cancer LetterFreeHealth Equity

Ben Harder: U.S. News may use health equity measures to rank hospitals in the future

July 30, 2021
Vol.47 No.30
By Matthew Bin Han Ong
Should hospitals, cancer centers be ranked according to their health equity scorecards?
FreeHealth Equity

Should hospitals, cancer centers be ranked according to their health equity scorecards?
Winn, Knudsen, Mesa, Willman discuss the health equity measures introduced by U.S. News & World Report

July 30, 2021
Vol.47 No.30
By Matthew Bin Han Ong
Institutions will be required to report sexual misconduct to NIH if House committee bill becomes law
Capitol HillFree

Institutions will be required to report sexual misconduct to NIH if House committee bill becomes law

July 23, 2021
Vol.47 No.29
By Matthew Bin Han Ong
House subcommittee slates $6.5B increase for NIH: $3B for ARPA-H and $3.5B for research, adding $432M to FY22 NCI budget
Capitol Hill

House subcommittee slates $6.5B increase for NIH: $3B for ARPA-H and $3.5B for research, adding $432M to FY22 NCI budget

July 16, 2021
Vol.47 No.28
AACR requests $7.6 billion for NCI
Capitol Hill

AACR requests $7.6 billion for NCI

July 09, 2021
Vol.47 No.27
By Alexandria Carolan
Annual Report to the Nation: Declines in lung cancer, melanoma death rates drive overall cancer mortality drop

Annual Report to the Nation: Declines in lung cancer, melanoma death rates drive overall cancer mortality drop

July 09, 2021
Vol.47 No.27
By Alexandria Carolan
Single digits: Black, Hispanic scientists strikingly underrepresented at NCI among senior workforce and grantees
FreeHealth Equity

Single digits: Black, Hispanic scientists strikingly underrepresented at NCI among senior workforce and grantees

July 02, 2021
Vol.47 No.26
By Matthew Bin Han Ong
Racial, ethnic minorities are systemically underrepresented in leadership teams across NCI cancer centers
Conversation with The Cancer LetterFreeHealth Equity

Racial, ethnic minorities are systemically underrepresented in leadership teams across NCI cancer centers

June 25, 2021
Vol.47 No.25
By Matthew Bin Han Ong
Will cancer centers remain committed to improving equity in the long term?
FreeHealth Equity

Will cancer centers remain committed to improving equity in the long term?
Cancer center leaders discuss their hiring and diversity pipeline efforts

June 25, 2021
Vol.47 No.25
By Matthew Bin Han Ong

Posts navigation

Previous1…353637Next

Trending Stories

  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
  • Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
  • One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
  • As more people are surviving cancer, we must continue funding bold science
  • GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
    Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account